BioGaia

129.50 SEK

-1.15 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

-1.15 %
+7.38 %
+24.88 %
+21.94 %
+24.40 %
+23.33 %
+27.21 %
+59.88 %
+1,723.09 %

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Read more
Market cap
13.1B SEK
Turnover
14.15M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
39.36
Dividend yield-%
3.09 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7
2026

Interim report Q2'26

22.10
2026

Interim report Q3'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.